Ellicott City, MD, United States of America

Luis Diaz

USPTO Granted Patents = 26 


 

Average Co-Inventor Count = 6.5

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Ellicott City, MD (US) (2018 - 2023)
  • Ellicot City, MD (US) (2020 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
26 patents (USPTO):Explore Patents

Title: Innovations in Cancer Research: The Patents of Luis Diaz

Introduction

Luis Diaz is an influential inventor based in Ellicott City, Maryland, renowned for his groundbreaking contributions to cancer research. With an impressive portfolio of 24 patents, his work has significantly advanced the detection and treatment of tumors, particularly in challenging cases where conventional methods fall short.

Latest Patents

Among his recent patents, two stand out for their potential impact on patient management:

1. **Detection of Tumor-Derived DNA in Cerebrospinal Fluid** - This innovative approach focuses on analyzing cerebrospinal fluid (CSF) to detect tumor-derived DNA, which is often undetectable in blood samples. The findings suggest that CSF-derived tumor DNA could be invaluable for the management of patients suffering from primary tumors of the brain or spinal cord.

2. **Checkpoint Blockade and Microsatellite Instability** - This patent addresses the application of immune checkpoint blockade therapies, specifically targeting CTLA-4 and PD-1 receptors. These therapies have shown promise in promoting anti-tumor immunity in certain types of cancers, making them advantageous for patients presenting with a myriad of neoantigens in their tumors.

Career Highlights

Luis Diaz has had a thriving career in prestigious research institutions, including The Johns Hopkins University and Duke University. His work has not only led to numerous patents but also has contributed to significant advancements in the understanding of cancer biology and treatment methodologies.

Collaborations

Throughout his career, Diaz has had the privilege to collaborate with esteemed professionals such as Kenneth W. Kinzler and Bert Vogelstein. Their joint efforts have created a cumulative impact in the cancer research field, facilitating breakthroughs that have the potential to improve patient outcomes.

Conclusion

Luis Diaz exemplifies the essence of innovation in the field of cancer research through his assortment of patents and collaborations. His ongoing commitment to advancing science positions him as a key player in the quest for effective cancer detection and treatment methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…